Skip to main content

Month: June 2022

With 5.1% CAGR, Global Online Trading Platform Market Size Worth USD 12.16 Billion in 2028

According to Fortune Business Insights, the global Online Trading Platform Market Size is projected to reach USD 12.16 billion in 2028, at CAGR of 5.1% during forecast period [2021-2028]; Utilization of Artificial Intelligence with Electronic Platforms to Aid Growth Pune, India, June 14, 2022 (GLOBE NEWSWIRE) — The global online trading platform market is set to gain impetus from the rising integration of artificial intelligence (AI) with electronic trading platform solutions. Chatbots help users to receive market estimations, data about the trader’s notifications, account reports, real-time estimates, and generic FAQs. In February 2021, for instance, HSBC unveiled a pricing chatbot that utilizes AI to provide instant analytics and pricing for foreign exchange (FX) options to clients. This information is given by Fortune...

Continue reading

With 5.3% CAGR, Kidney Stone Management Market Size to Surpass Around USD 2.21 Billion in 2028

According to Fortune Business Insights, Kidney Stone Management Market was valued at USD 1.47 billion in 2019 and is anticipated to rise at a CAGR of 5.3% to reach USD 2.21 billion by the end of 2028. Advent of Miniaturized Surgery to Propel Growth Pune, India, June 14, 2022 (GLOBE NEWSWIRE) — The global kidney stone management market size is expected to rise prominently on account of the increasing cases of kidney stone among people worldwide. This is further attributed to the formation of crystal-like substances such as uric acid, oxalate, and calcium which cannot be diluted in the urine as a result of consuming food and drinks that are rich in phosphate and oxalate. A recent report by Fortune Business Insights, titled, “Kidney Stone Management Market Size, Share & COVID-19 Impact Analysis, By Type (Lithotripsy, Ureteroscopy,...

Continue reading

With 4.4% CAGR, Medical X-ray Market Size to Surpass Around USD 16.86 billion by 2028

According to Fortune Business Insights, Advanced Automated X-ray System by Aroma AB to Aid Medical X-ray Market Reach USD 16.86 Billion by 2028; Medical X-ray Market Witnesses Colossal Growth Backed by Siemens Healthiness Introducing First-ever Intelligent X-ray System Pune, India, June 14, 2022 (GLOBE NEWSWIRE) — The global medical x-ray market size is expected to reach USD 16.86 billion by 2028 while exhibiting a CAGR of 4.4% between 2021 and 2028. This information is published by Fortune Business Insights in its latest report, titled, “Medical X-ray Market, 2021-2028.” The report further mentions that the market stood at USD 12.14 billion in 2020 and is expected to experience exponential growth in the forthcoming years. This growth is attributable to the increasing prevalence of chronic disorders and the rising geriatric population...

Continue reading

With 13.4% CAGR, Global Cyber Security Market Size to Surpass USD 376.32 Billion in 2029

According to Fortune Business Insights, the global Cyber Security Market Size is projected to reach USD 376.32 billion in 2029, at CAGR of 13.4% during forecast period; Rising Number of E-commerce Platforms to Drive the Market Growth Pune, India, June 14, 2022 (GLOBE NEWSWIRE) — The global Cyber Security Market Size is projected to reach USD 376.32 Billion by 2029, from 139.77 Billion in 2021, at a Compound Annual Growth Rate (CAGR) of 13.4% during the forecast period. Fortune Business Insights has presented this information in its report titled, “Global Cyber Security Market Share, 2022-2029”. Emerging online e-commerce platforms and the introduction of essential technologies such as the internet of things (IoT), cloud security, artificial intelligence (AI), and others are driving the market. The development of internet security...

Continue reading

NXP Debuts New MCX Portfolio of Microcontrollers for the Next Era of Advanced Industrial and IoT Edge Computing

NXP Debuts New MCX Portfolio of Microcontrollers for the Next Era of Advanced Industrial and IoT Edge Computing NXP Semiconductors today announced the new MCX portfolio of microcontrollers, designed to advance innovation in smart homes, smart factories, smart cities and many emerging industrial and IoT edge applications. The portfolio includes four series of devices built on a common platform and is supported by the widely adopted MCUXpresso suite of development tools and software.The new MCX microcontroller (MCU) portfolio features four new series of devices, built on a common platform and supported by NXP’s widely adopted MCUXpresso suite of development tools and software to simplify product developmentThe Arm® Cortex®-M core-based MCX portfolio includes the high-performance MCX N series, cost-optimized and analog-focused MCX...

Continue reading

Atos completes the sale of its entire stake in Worldline

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN, OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Paris, France – June 14, 2022 – Atos has completed the sale of its entire stake in Worldline of ca. 7.0 million shares representing ca. 2.5% of Worldline’s share capital. The sale was carried out by way of an accelerated book building to institutional investors (the “Placement”).  Atos has concomitantly entered into a derivative transaction to hedge its residual exposure to Worldline’s shares related to the outstanding exchangeable bonds due 2024, which were issued in 2019.   As a result of the Placement and derivative transaction, Atos has raised net proceeds of ca. €220 million and will no longer be a shareholder of Worldline.  Goldman...

Continue reading

Van Lanschot Kempen: update on share buy-back programme 7 June 2022 – 13 June 202

Amsterdam/’s-Hertogenbosch, the Netherlands, 14 June 2022 In the period from 7 June 2022 until 13 June 2022 Van Lanschot Kempen has repurchased 47,390 of its own shares (depositary receipts for Class A ordinary shares). The shares were repurchased at an average price of €23.75 per share for a total amount of €1,125,304.                 These repurchases are part of the share buy-back programme for at most 600,000 of own shares, which was announced on 24 February 2022. The total number of shares repurchased to date is 461,835. More information, including a detailed overview of the repurchase transactions under this programme, is available on www.vanlanschotkempen.com/sharebuyback. Media Relations: +31 20 354 45 85; mediarelations@vanlanschotkempen.comInvestor Relations: +31 20 354 45 90; investorrelations@vanlanschotkempen.com About Van...

Continue reading

UPM raises its earnings outlook for 2022

UPM-Kymmene Corporation        Stock Exchange Release (Inside information)        14 June 2022 at 09:25 EEST UPM raises its earnings outlook for 2022 UPM raises its earnings outlook for H1 2022 and for the full year 2022. The company now expects its comparable EBIT to increase both in H1 2022 from H1 2021, and in the full year 2022 from 2021. Earlier, the company expected its comparable EBIT in H1 2022 to be on similar level compared to H1 2021, while comparable EBIT in the full year 2022 was expected to be on similar level or higher than in 2021. UPM’s comparable EBIT totalled EUR 586 million in H1 2021, and EUR 1,471 million in the full-year 2021. Strong market conditions have continued in all UPM businesses. The company has succeeded well in managing margins in the challenging cost environment. Furthermore, production ramp-up succeeded...

Continue reading

Proactive news headlines including Westar Resources, KGL Resources, Noxopharm and Eclipse Metals

Sydney, June 14, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Westar Resources Ltd (ASX:WSR) has confirmed the potential for significant copper-zinc mineralisation from its maiden reverse circulation (RC) drill program at the Gidgee North Project in the Meekatharra-Sandstone region of Western Australia. Click here KGL Resources Ltd (ASX:KGL) has strengthened its board with the appointment of resources and energy sector veteran Ian Williams as a non-executive director. Click here Noxopharm Ltd (ASX:NOX)’s collaborator Hudson Institute of Medical Research has landed a $100,000 grant from mRNA Victoria Acceleration Fund to study RNA-based therapeutics. Click here Eclipse Metals Ltd (ASX:EPM) has welcomed some pleasing...

Continue reading

ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions

Acquisition creates a global leader in out-of-hospital software solutions Accelerates ResMed’s SaaS strategy by extending ResMed’s position as a leading U.S. provider of SaaS solutions in out-of-hospital care settings into Germany MEDIFOX DAN will integrate into ResMed’s out-of-hospital SaaS business segment, expanding its solutions portfolio into new healthcare sectors including outpatient therapy Purchase price of approximately US$1 billion Upon closing, acquisition expected to be accretive to ResMed’s non-GAAP diluted earnings per shareSAN DIEGO and HILDESHEIM, Germany, June 14, 2022 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) today announced a definitive agreement to acquire privately held MEDIFOX DAN, a German leader in out-of-hospital software solutions for providers in major settings across the care continuum, from...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.